We are happy to share that we have two abstracts for the poster sessions at the American Association for Cancer Research (AACR) Annual Meeting 2023. For the first poster, we developed a prostate cancer PDX model radioresistant to PSMA targeted radionuclide therapy. In the second poster, we evaluated stereotactic vs. intracarotid inoculation for intracranial breast cancer brain metastases (BCBM) models. Both posters will be presented on Tuesday April 18 in the afternoon. Information on poster sessions and location can be found below.

Interested in learning more about Minerva Imaging or scheduling a meeting during the AACR 2023? Click here to reach out to Fabian Pruissen, Business Developer. Or drop by our booth #312

Development of a prostate cancer PDX model radioresistant to PSMA targeted radionuclide therapy

Intracranial breast cancer brain metastases (BCBM) models – stereotactic vs. intracarotid inoculation

More info: